Research Group – name pending
A team of researchers led by scientists that has developed fluorescent lateral flow test (FLFT) for our early detection cancer rapid tests.
A fluorescent lateral flow test (FLFT) is a diagnostic method that combines traditional lateral flow assay technology with fluorescent labels to enhance sensitivity and quantification. Unlike conventional lateral flow tests that use colloidal gold or colored dyes, FLFTs utilize fluorescent nanoparticles, quantum dots, or fluorescent dyes, enabling the detection and measurement of analytes at significantly lower concentrations.
ey Advantages:
- Higher Sensitivity: Capable of detecting biomarkers at very low levels.
- Quantitative Analysis: Allows precise measurement of biomarker concentration.
- Enhanced Accuracy: Reduces ambiguity by providing clearer results through fluorescence detection.
- Rapid and User-Friendly: Maintains the simplicity, portability, and rapid results of traditional lateral flow assays.
Typical Applications:
- Cancer biomarker detection
- Infectious disease diagnosis
- Hormone and metabolic testing
- Environmental and food safety monitoring
Principle:
Fluorescent molecules or particles are attached to antibodies or antigen-specific probes. When the test is run, target molecules in the sample bind these fluorescently labeled probes, forming complexes that accumulate at a specific region on the test strip. A specialized reader or handheld fluorescence detector then illuminates the test line, measuring emitted fluorescence to quantify the presence and concentration of the target analyte.